A Phase 2a Diabetic Kidney Disease Study

Condition:   Diabetic Kidney Disease Interventions:   Drug: MEDI3506;   Drug: Placebo Sponsor:   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials